Literature DB >> 32644211

Clearance of JC polyomavirus from cerebrospinal fluid following treatment with interleukin-2 and pembrolizumab in an individual with progressive multifocal leukoencephalopathy and no underlying immune deficiency syndrome.

Y Goereci1, F Schweitzer1, A Wellstein2, S Silling3, S Borchmann4, B von Tresckow5, O Adams6, R Martin7, M Schlamann8, M Schroeter1, G R Fink1,9, M P Wattjes10, C Warnke1.   

Abstract

Entities:  

Year:  2020        PMID： 32644211     DOI： 10.1111/ene.14435

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN： 1351-5101            Impact factor:   6.089


× No keyword cloud information.
  6 in total

Review 1.  Promise and Challenges of Checkpoint Inhibitor Therapy for Progressive Multifocal Leukoencephalopathy in HIV.

Authors:  Sydney Corey; Bryan R Smith; Irene C M Cortese
Journal:  Curr HIV/AIDS Rep       Date:  2022-10-01       Impact factor: 5.495

2.  Pembrolizumab for the treatment of progressive multifocal leukoencephalopathy following anti-CD19 CAR-T therapy: a case report.

Authors:  Strachan Mackenzie; Manar Shafat; Harriet Roddy; Harpreet Hyare; Lorna Neill; Maria A V Marzolini; Michael Gilhooley; Teresa Marafioti; Eleanna Kara; Emilie Sanchez; Jeremy Rees; David S Lynch; Kirsty Thomson; Kirit M Ardeshna; Arian Laurence; Karl S Peggs; Maeve O'Reilly; Claire Roddie
Journal:  EJHaem       Date:  2021-08-04

Review 3.  Advances in Treatment of Progressive Multifocal Leukoencephalopathy.

Authors:  Raphaël Bernard-Valnet; Igor J Koralnik; Renaud Du Pasquier
Journal:  Ann Neurol       Date:  2021-09-07       Impact factor: 11.274

4.  Pembrolizumab for the treatment of Progressive Multifocal Leukoencephalopathy (PML) in a patient with AIDS: A case report and literature review.

Authors:  Tulika Chatterjee; Moni Roy; Rone-Chun Lin; Mohammad O Almoujahed; Sharjeel Ahmad
Journal:  IDCases       Date:  2022-05-20

5.  PD-1-inhibitor pembrolizumab for treatment of progressive multifocal leukoencephalopathy.

Authors:  Nora Möhn; Mike P Wattjes; Ortwin Adams; Sandra Nay; Daria Tkachenko; Friederike Salge; Johanne Heine; Kaweh Pars; Günter Höglinger; Gesine Respondek; Martin Stangel; Thomas Skripuletz; Roland Jacobs; Kurt-Wolfram Sühs
Journal:  Ther Adv Neurol Disord       Date:  2021-03-09       Impact factor: 6.570

Review 6.  Innovative therapeutic concepts of progressive multifocal leukoencephalopathy.

Authors:  Nora Möhn; Lea Grote-Levi; Franziska Hopfner; Britta Eiz-Vesper; Britta Maecker-Kolhoff; Clemens Warnke; Kurt-Wolfram Sühs; Mike P Wattjes; Günter U Höglinger; Thomas Skripuletz
Journal:  J Neurol       Date:  2022-01-07       Impact factor: 6.682
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.